Israeli biotech firm Kadmastem procures $5.15 mln

Kadimastem, an Israeli biotech company, has raised $5.15 million in a private placement. The investors included Altshuler Shaham Investment House.

2 October 2018•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.